BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3225412)

  • 1. Prostaglandins influence myofibroblast contractility in Dupuytren's disease.
    Badalamente MA; Hurst LC; Sampson SP
    J Hand Surg Am; 1988 Nov; 13(6):867-71. PubMed ID: 3225412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pathobiology of Dupuytren's contracture: effects of prostaglandins on myofibroblasts.
    Hurst LC; Badalamente MA; Makowski J
    J Hand Surg Am; 1986 Jan; 11(1):18-23. PubMed ID: 3456001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacologic regulation of Dupuytren's fibroblast contraction in vitro.
    Rayan GM; Parizi M; Tomasek JJ
    J Hand Surg Am; 1996 Nov; 21(6):1065-70. PubMed ID: 8969433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-transcriptional regulation of alpha-smooth muscle actin determines the contractile phenotype of Dupuytren's nodular cells.
    Verjee LS; Midwood K; Davidson D; Eastwood M; Nanchahal J
    J Cell Physiol; 2010 Sep; 224(3):681-90. PubMed ID: 20432463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of alpha-smooth muscle actin expression and contraction in Dupuytren's disease fibroblasts.
    Tomasek J; Rayan GM
    J Hand Surg Am; 1995 May; 20(3):450-5. PubMed ID: 7642925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of contractile force by cultured Dupuytren's disease and normal palmar fibroblasts.
    Rayan GM; Tomasek JJ
    Tissue Cell; 1994 Oct; 26(5):747-56. PubMed ID: 9437248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of 5-fluorouracil on Dupuytren fibroblast proliferation and differentiation.
    Jemec B; Linge C; Grobbelaar AO; Smith PJ; Sanders R; McGrouther DA
    Chir Main; 2000 Feb; 19(1):15-22. PubMed ID: 10777424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adipose-derived stem cells inhibit the contractile myofibroblast in Dupuytren's disease.
    Verhoekx JSN; Mudera V; Walbeehm ET; Hovius SER
    Plast Reconstr Surg; 2013 Nov; 132(5):1139-1148. PubMed ID: 23924646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dupuytren's fibroblast contractility by sphingosine-1-phosphate is mediated through non-muscle myosin II.
    Komatsu I; Bond J; Selim A; Tomasek JJ; Levin LS; Levinson H
    J Hand Surg Am; 2010 Oct; 35(10):1580-8. PubMed ID: 20888494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular structure and biology of Dupuytren's disease.
    Tomasek JJ; Vaughan MB; Haaksma CJ
    Hand Clin; 1999 Feb; 15(1):21-34. PubMed ID: 10050239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The myofibroblast in Dupuytren's contracture.
    Rudolph R; Vande Berg J
    Hand Clin; 1991 Nov; 7(4):683-92; discussion 693-4. PubMed ID: 1769990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unraveling the signaling pathways promoting fibrosis in Dupuytren's disease reveals TNF as a therapeutic target.
    Verjee LS; Verhoekx JS; Chan JK; Krausgruber T; Nicolaidou V; Izadi D; Davidson D; Feldmann M; Midwood KS; Nanchahal J
    Proc Natl Acad Sci U S A; 2013 Mar; 110(10):E928-37. PubMed ID: 23431165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tamoxifen decreases fibroblast function and downregulates TGF(beta2) in dupuytren's affected palmar fascia.
    Kuhn MA; Wang X; Payne WG; Ko F; Robson MC
    J Surg Res; 2002 Apr; 103(2):146-52. PubMed ID: 11922728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of bone morphogenetic proteins by Dupuytren's fibroblasts.
    Shin SS; Liu C; Chang EY; Carlson CS; Di Cesare PE
    J Hand Surg Am; 2004 Sep; 29(5):809-14. PubMed ID: 15465229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dupuytren's disease susceptibility gene, EPDR1, is involved in myofibroblast contractility.
    Staats KA; Wu T; Gan BS; O'Gorman DB; Ophoff RA
    J Dermatol Sci; 2016 Aug; 83(2):131-7. PubMed ID: 27245865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pathogenesis of Dupuytren's contracture: contractile mechanisms of the myofibroblasts.
    Badalamente MA; Stern L; Hurst LC
    J Hand Surg Am; 1983 May; 8(3):235-43. PubMed ID: 6683733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in alpha smooth muscle actin expression between fibroblasts derived from Dupuytren's nodules or cords.
    Dave SA; Banducci DR; Graham WP; Allison GM; Ehrlich HP
    Exp Mol Pathol; 2001 Oct; 71(2):147-55. PubMed ID: 11599921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Responsiveness of Dupuytren's disease fibroblasts to 5 alpha-dihydrotestosterone.
    Pagnotta A; Specchia N; Soccetti A; Manzotti S; Greco F
    J Hand Surg Am; 2003 Nov; 28(6):1029-34. PubMed ID: 14642522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Androgen receptors in Dupuytren's contracture.
    Pagnotta A; Specchia N; Greco F
    J Orthop Res; 2002 Jan; 20(1):163-8. PubMed ID: 11853085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The biochemistry of Dupuytren's disease.
    Badalamente MA; Hurst LC
    Hand Clin; 1999 Feb; 15(1):35-42, v-vi. PubMed ID: 10050240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.